Skip to main content
. 2022 Aug 18;82(19):3614–3621. doi: 10.1158/0008-5472.CAN-22-0900

Figure 1.

Figure 1. Flow chart of study population. Note: *Extending adjuvant hormone therapy was defined as continuing the therapy for ≥ 6 months and filling ≥ 2 prescriptions of tamoxifen or aromatase inhibitors beyond the 5-year adjuvant hormone therapy.

Flow chart of study population. Note: Extending adjuvant hormone therapy was defined as continuing the therapy for ≥6 months and filling ≥2 prescriptions of tamoxifen or aromatase inhibitors beyond the 5-year adjuvant hormone therapy.